Sarah Larney

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013

Louisa Degenhardt, Fiona Charlson, Jeffrey D Stanaway et al. · The Lancet Infectious Diseases · 2016 · 301 citations · Full text

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

Jason Grebely, Sarah Larney, Amy Peacock et al. · Addiction · 2018 · 253 citations · Full text

The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

Adam Trickey, Hannah Fraser, Aaron G. Lim et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 235 citations · Full text

Vaccination, Hepatology, Hepatitis C +11

Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial

Josiah D. Rich, Michelle McKenzie, Sarah Larney et al. · The Lancet · 2015 · 229 citations · Full text

Open-label Trial, Substance Abuse, Methadone Continuation Versus +15

The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study

Louisa Degenhardt, Sarah Larney, Jo Kimber et al. · Addiction · 2014 · 225 citations